Department of Pathology, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Neurogenetics Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Neuropathol Appl Neurobiol. 2021 Aug;47(5):585-602. doi: 10.1111/nan.12696. Epub 2021 Feb 14.
Malformations of cortical development (MCD) include a heterogeneous spectrum of clinical, imaging, molecular and histopathological entities. While the understanding of genetic causes of MCD has improved with the availability of next-generation sequencing modalities, genotype-histopathological correlations remain limited. This is the first systematic review of molecular and neuropathological findings in patients with MCD to provide a comprehensive overview of the literature.
A systematic review was performed between November 2019 and February 2020. A MEDLINE search was conducted for 132 genes previously linked to MCD in order to identify studies reporting macroscopic and/or microscopic findings in patients with a confirmed genetic cause.
Eighty-one studies were included in this review reporting neuropathological features associated with pathogenic variants in 46 genes (46/132 genes, 34.8%). Four groups emerged, consisting of (1) 13 genes with well-defined histological-genotype correlations, (2) 27 genes for which neuropathological reports were limited, (3) 5 genes with conflicting neuropathological features, and (4) 87 genes for which no histological data were available. Lissencephaly and polymicrogyria were reported most frequently. Associated brain malformations were variably present, with abnormalities of the corpus callosum as most common associated feature.
Neuropathological data in patients with MCD with a defined genetic cause are available only for a small number of genes. As each genetic cause might lead to unique histopathological features of MCD, standardised thorough neuropathological assessment and reporting should be encouraged. Histological features can help improve the understanding of the pathogenesis of MCD and generate hypotheses with impact on further research directions.
皮质发育畸形(MCD)包括一系列临床表现、影像学表现、分子和组织病理学特征各不相同的实体。虽然随着下一代测序技术的出现,人们对 MCD 的遗传病因的理解有所提高,但基因型-组织病理学相关性仍然有限。这是第一篇对 MCD 患者的分子和神经病理学发现进行的系统综述,旨在提供该领域文献的全面概述。
本系统综述于 2019 年 11 月至 2020 年 2 月进行。对先前与 MCD 相关的 132 个基因进行了 MEDLINE 搜索,以确定报告具有明确遗传病因的患者的宏观和/或微观发现的研究。
本综述纳入了 81 项研究,这些研究报道了与 46 个基因(46/132 个基因,34.8%)致病性变异相关的神经病理学特征。有 4 个组,分别为:(1)13 个具有明确组织学-基因型相关性的基因;(2)神经病理学报道有限的 27 个基因;(3)5 个神经病理学特征存在冲突的基因;(4)87 个无组织学数据的基因。无脑回畸形和多小脑回畸形报道最常见。常伴有其他脑畸形,胼胝体异常是最常见的相关特征。
仅有少数明确遗传病因的 MCD 患者具有神经病理学数据。由于每种遗传病因可能导致独特的 MCD 组织病理学特征,因此应鼓励进行标准化的全面神经病理学评估和报告。组织学特征有助于加深对 MCD 发病机制的理解,并为进一步的研究方向提供假说。